|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the ELN 6-K filed Mar 31, 2006. Capital Expenditures and
Investment
The decrease in intangible fixed assets to $815.2 million
at 31 December 2005 from $1,013.0 million at
31 December 2004 primarily reflects amortisation charges of
$156.3 million. The increase in property, plant and
equipment to $344.6 million at 31 December 2005 from
$338.9 million at 31 December 2004 reflects net
additions of $38.8 million and the depreciation charge for
the year of $33.1 million. The decrease in
available-for-sale investments to $24.5 million at
31 December 2005 from $91.9 million at
31 December 2004 primarily reflects impairment charges of
$31.7 million and disposals of $37.3 million. Our
capital expenditures during 2005 amounted to $42.5 million
(2004: $62.4 million) and include the completion of a
sterile fill and finish facility in Athlone, Ireland, where our
EDT business has its principal manufacturing and development
facilities.
We believe that our current and planned manufacturing, research,
product development and corporate facilities will adequately
meet our current and projected needs. We will use our resources
to make capital expenditures as necessary from time to time and
also to make investments in the purchase or licensing of
products and technologies and in marketing and other alliances
with third parties to support our long term strategic objectives.
This excerpt taken from the ELN 6-K filed Apr 11, 2005. Capital Expenditures and Investment The decrease in intangible fixed assets to $1,019.5 million at 31 December 2004 from $1,252.4 million at 31 December 2003 primarily reflects disposals of $150.3 million, and amortisation charges of $109.3 million. The decrease in tangible fixed assets to $346.2 million at 31 December 2004 from $372.2 million at 31 December 2003 primarily reflects the disposal of and impairments to assets as part of our recovery plan, along with the depreciation charge for the year. The decrease in non-current financial fixed assets to $91.9 million at 31 December 2004 from $407.9 million at 31 December 2003 primarily reflects impairment charges of $74.7 million and disposals/repayments of $286.0 million, offset by additions/conversions of $43.3 million. Our capital expenditures during 2004 amounted to $57.9 million (2003: $33.7 million). We believe that our current and planned manufacturing, research, product development and corporate facilities will adequately meet our current and projected needs. We will use our resources to make capital expenditures as necessary from time to time and also to make investments in the purchase or licensing of products and technologies and in marketing and other alliances with third parties to support our long term strategic objectives.
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for ELN: |
| |||||||
